Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Matthew Frieman and Gale Smith.
Matthew Frieman
Connection Strength
1.000
Gale Smith
  1. SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice. Nat Commun. 2021 01 14; 12(1):372.
    View in: PubMed
    Score: 0.231
  2. NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. Vaccine. 2020 11 25; 38(50):7892-7896.
    View in: PubMed
    Score: 0.227
  3. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection. Vaccine. 2017 03 14; 35(12):1586-1589.
    View in: PubMed
    Score: 0.176
  4. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Sci Transl Med. 2016 Feb 17; 8(326):326ra21.
    View in: PubMed
    Score: 0.164
  5. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 2014 May 30; 32(26):3169-3174.
    View in: PubMed
    Score: 0.145
  6. Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. N Engl J Med. 2020 12 10; 383(24):2320-2332.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.